Pharma Journalist -

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...

Gilead Sciences has renewed its collaboration with the World Health Organization (WHO) for another five years, strengthening efforts to eliminate visceral leishmaniasis (VL), commonly…
Read More...

Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global initiative aimed at building an open surgical intelligence network, positioning Abu…
Read More...

Regeneron Pharmaceuticals reported encouraging early-stage results from a Phase 1/2 clinical trial evaluating Lynozyfic (linvoseltamab) in patients with relapsed or treatment-resistant…
Read More...

Eli Lilly and Company has acquired preclinical biotechnology company Engage Biologics Inc. in a deal worth up to $202 million, strengthening the drugmaker’s ambitions in next-generation…
Read More...

SERB Pharmaceuticals and Hansa Biopharma have entered into an agreement under which SERB will acquire exclusive development and commercialization rights to Idefirix (imlifidase) across…
Read More...

QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...

Global pharmaceutical company Merck & Co. has announced positive pivotal Phase 3 results for sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug…
Read More...

Takeda Pharmaceutical Company said a U.S. federal jury has returned a verdict against the company in long-running antitrust litigation involving constipation drug AMITIZA, awarding…
Read More...

Regeneron Pharmaceuticals has entered into a strategic research collaboration with Parabilis Medicines to discover and develop a new class of therapeutics designed to target…
Read More...